Streetbeat News

Price Targets

UPST

Upstart Holdings, Inc. (NASDAQ:UPST) shares are trading higher following a 50 basis point interest rate cut by the Federal Reserve. This cut could benefit Upstart's loan segments by attracting more borrowers. Additionally, Upstart announced an upsized private offering of $375 million in convertible senior notes. Despite the current rally, analysts have mixed ratings on UPST, with an average price target suggesting potential downside.

Portfolio Pulse from Erica Kollmann

September 19, 2024 | 3:53 pm

FDMT

Chardan Capital has maintained its Buy rating on 4D Molecular Therapeutics (NASDAQ:FDMT) and raised the price target from $38 to $39.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 3:51 pm

MUSA

Murphy USA shares declined following a downgrade by JP Morgan from Neutral to Underweight, despite an increase in the price target from $415 to $435.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 3:49 pm

DRVN

Canaccord Genuity has maintained its Buy rating on Driven Brands Holdings and raised the price target from $19 to $20, indicating a positive outlook for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 3:49 pm

MU

TD Cowen analyst Karl Ackerman maintains a Buy rating on Micron Technology but lowers the price target from $160 to $115.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 3:48 pm

HLX

Helix Energy Solutions shares rose after Raymond James initiated coverage with a Strong Buy rating and set a price target of $14.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 3:47 pm

CBUS

Canaccord Genuity has maintained its Buy rating on Cibus (NASDAQ:CBUS) but has lowered the price target from $21 to $20.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 3:47 pm

HOG

Citigroup analyst James Hardiman maintains a Neutral rating on Harley-Davidson (NYSE:HOG) and raises the price target from $37 to $39.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 3:43 pm

APLT

Applied Therapeutics shares rose following increased price targets from Leerink Partners and Citigroup.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 3:41 pm

MTN

Stifel analyst Jeffrey Stantial maintains a Buy rating on Vail Resorts (NYSE:MTN) but lowers the price target from $259 to $223.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 3:40 pm